CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands		Mar. 31, 2026	Dec. 31, 2025
Common stock, par value (in dollars per share)		$ 0.01	$ 0.01
Common stock, shares authorized (in shares)		2,000,000,000	2,000,000,000
Common stock, shares issued (in shares)		102,580,660	102,573,283
Common stock, shares outstanding (in shares)		102,580,660	102,573,283
Preferred stock, par value (in dollars per share)		$ 0.01	$ 0.01
Preferred stock, shares authorized (in shares)		200,000,000	200,000,000
Preferred stock, shares issued (in shares)		6,800,000	6,800,000
Preferred stock, shares outstanding (in shares)		6,800,000	6,800,000
Accounts receivable, net	[1]	$ 176,873	$ 209,907
Other current assets	[2]	561,202	408,364
Equity Method Investee
Accounts receivable, net		35,422	47,294
Other current assets		$ 18,908	$ 20,681

[1] Includes accounts receivable from the 2025 Partnership of $35,422 and $47,294 as of March 31, 2026 and December 31, 2025, respectively.

[2] Includes receivables from the 2025 Partnership of $18,908 and $20,681 as of March 31, 2026 and December 31, 2025, respectively.